Administration of anti-interleukin 18 antibody fails to inhibit development of dermatitis in atopic dermatitis-model mice NC/Nga

British Journal of Dermatology

Volumn 149, Issue 1, 2003, Pages 39-45

  Higa, S ^a   Kotani, M ^b   Matsumoto, M ^b   Fujita, A ^b   Hirano, T ^a   Suemura, M ^c   Kawase, I ^a   Tanaka, Toshio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Sunstar Inc   (Japan)

^c NISSAY HOSPITAL   (Japan)

Author keywords

Atopic dermatitis; Interleukin 18; NC Nga mouse

Indexed keywords

CYTOKINE ANTIBODY; INTERLEUKIN 18; INTERLEUKIN 18 ANTIBODY; INTERLEUKIN 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; HYPERSENSITIVITY REACTION; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCRATCHING; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; BEHAVIOR, ANIMAL; CELLS, CULTURED; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; IMMUNOGLOBULIN E; INTERLEUKIN-18; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; PRURITUS;

EID: 0042635677     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05406.x     Document Type: Article

References (23)

1. Okamura H, Tsutsui H, Komatsu T et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 1995; 378: 88-91.
2. Okamura H, Tsutsui H, Kashiwamura S et al. Interleukin-18 (IL-18) a novel cytokine that augments both innate and acquired immunity. Adv Immunol 1998; 70: 281-312.
3. Dinarello CA. IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999; 103: 11-24.
4. Yoshimoto T, Okamura H, Tagawa A et al. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon γ production from activated B cells. Proc Natl Acad Sci USA 1997; 94: 3948-53.
5. Yoshimoto T, Tsutsui H, Tominaga K et al. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci USA 1999; 96: 13962-6.
6. Hoshino T, Wiltrout RH, Young HA. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol 1999; 162: 5070-7.
7. + T cells, IL-4 and STAT6. Nature Immunol 2000; 1: 132-7.
8. Nakanishi K, Yoshimoto T, Tsutsui H et al. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001; 19: 423-74.
9. Matsuda H, Watanabe N, Geba GP et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997; 9: 461-6.
10. Kotani M, Matsumoto M, Fujita A et al. Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J Allergy Clin Immunol 2000; 106: 159-66.
11. Tanaka T, Tsutsui H, Yoshimoto T et al. Interleukin-18 is elevated in the sera from patients with atopic dermatitis and from atopic dermatitis-model mice, NC/Nga. Int Arch Allergy Immunol 2001; 125: 236-40.
12. Kawakami K, Qureshi MH, Zhang T et al. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. J Immunol 1997; 159: 5528-34.
13. Seder RA, Gazzinelli R, Sher A et al. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci USA 1993; 90: 10188-92.
14. Tanaka T, Chu CC, Paul WE. An antisense oligonucleotide complementary to a sequence in Iγ2b increases γ2b germline transcripts, stimulates B cell DNA synthesis, and inhibits immunoglobulin secretion. J Exp Med 1992; 175: 597-607.
15. Matsumoto M, Ra C, Kawamoto K et al. IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J Immunol 1999; 162: 1056-63.
16. Yagi R, Nagai H, Iigo Y et al. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J Immunol 2002; 168: 2020-7.
17. Konishi H, Tsutsui H, Murakami T et al. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc Natl Acad Sci USA 2002; 99: 11340-5.
18. Grewe M, Bruijnzeel-Koomen CA, Schopf E et al. A role for Th1 and Th2 cells in immunopathogenesis of atopic dermatitis. Immunol Today 1998; 19: 359-61.
19. Grewe M, Gyufko K, Schopf E et al. Lesional expression of interferon-gamma in atopic eczema. Lancet 1994; 343: 25-6.
20. Habu Y, Seki S, Takayama E et al. The mechanism of a defective IFN-γ response to bacterial toxins in an atopic dermatitis model, NC/Nga mice, and the therapeutic effect of IFN-γ, IL-12, or IL-18 on dermatitis. J Immunol 2001; 166: 5439-47.
21. Biedermann T, Zimmermann S, Himmelrich H et al. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nature Immunol 2001; 2: 1054-60.
22. Sugaya M, Nakamura K, Tamaki K. Interleukin 18 and 12 synergistically upregulates interferon-gamma production by murine dendritic epidermal T cells. J Invest Dermatol 1999; 113: 350-4.
23. Naik SM, Cannon G, Burbach GJ et al. Human keratinocytes constitutively express interleukin-18 and secrete biological active interleukin-18 after treatment with pro-inflammatory mediators and dinitrochlorobenzene. J Invest Dermatol 1999; 113: 766-72.